Breaking News

Almac Completes Commercial API Facility

October 9, 2012

Will be operational by the end of the year

Almac’s expansion of its API manufacturing facility at its European Headquarters in Craigavon, UK has been completed and will be operational by the end of the year.  The expansion includes the installation of two 1,000L reactors and pressure filter dryer, which allows production of GMP API to 150kg batch size.
“Almac’s investment has further demonstrated our goal of being the outsourcing partner of choice through all stages of clinical development,” said Denis Geffroy, vice president of business development. “We are delighted to have the scale to share the manufacturing journey with our clients from preclinical phase to full commercialization.”
The expansion allows clients to leverage Almac’s API and drug product offering at the same site, allowing technology transfer of small molecule and peptide projects from lab development to large-scale manufacture.

blog comments powered by Disqus
  • CMC Biologics: Growing Through Innovation

    Tim Wright, Editor||January 28, 2016
    The new chief exec talks about industry trends and growth plans.

  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • A Look at DCAT Week ‘16

    Tim Wright, Editor||January 28, 2016
    On the pulse of the pharmaceutical manufacturing value chain, DCAT Week ‘16 will deliver top-flight education programs and networking events.